Grippe aviaire et transmission chez l'homme (2006) Delvallée/Documentation : Différence entre versions

De Wicri Santé
imported>Jacques Ducloy
(→‎Références bibliographiques)
imported>Jacques Ducloy
(→‎Références bibliographiques)
Ligne 15 : Ligne 15 :
  
 
4. OMS (2005). "WHO guidance on development of influenza vaccine reference viruses by reverse genetics." Organisation Mondiale de la Santé.
 
4. OMS (2005). "WHO guidance on development of influenza vaccine reference viruses by reverse genetics." Organisation Mondiale de la Santé.
 +
 +
5. OMS (2005). "Recommended laboratory tests to identify avian influenza A virus in specimens from humans." Organisation Mondiale de la Santé.
 +
 +
6. OMS (2006). "Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO." Organisation Mondiale de la Santé.
 +
 +
7. OMS (2006). "Avian influenza, including influenza A (H5N1), in humans : WHO interim infection control guideline for health care facilities." Organisation Mondiale de la Santé.
 +
 +
8. UPMC (2005). "Peramivir : Single Dose Prophylaxis for Flu?" Center for Biosecurity of UPMC, for a briefing on Capitol Hill.
 +
 +
9. Abed Y, Hardy I, Li Y and Boivin G (2002). "Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada." Journal of medical virology67(4) : 589-595.
 +
 +
10. Al Faress S, Cartet G, Ferraris O, Norder H, Valette M and Lina B (2005). "Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002." J Clin Virol33(3) : 230-6.
 +
 +
11. Alexander DJ, Van RK and Pensaert M (2000). "A review of avian influenza in different bird species." Veterinary microbiology  : (Amsterdam)74(1-2) : 3-13.
 +
 +
12. Amonsin A, Payungporn S, Theamboonlers A, Thanawongnuwech R, Suradhat S, Pariyothorn N, Tantilertcharoen R, Damrongwantanapokin S, Buranathai C, Chaisingh A, Songserm T and Poovorawan Y (2005). "Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand." Virology 344(2) : 480-491.
 +
 +
13. Apisarnthanarak A, Erb S, Stephenson I, Katz JM, Chittaganpitch M, Sangkitporn S, Kitphati R, Thawatsupha P, Waicharoen S, Pinitchai U, Apisarnthanarak P, Fraser VJ and Mundy LM (2005). "Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to Avian influenza (H5N1) in a tertiary care center." Clin Infect Dis 40(2) : e16-8.
 +
 +
14. Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, Auwanit W, Thawatsupha P, Chittaganpitch M, Saeng-Aroon S, Waicharoen S, Apisarnthanarak P, Storch GA, Mundy LM and Fraser VJ (2004). "Atypical avian influenza (H5N1)." Emerg Infect Dis 10(7) : 1321-4.
 +
 +
15. Aymard M, Gerentes L and Kessler N (1999). "Place des anticorps antineuraminidase dans la protection contre la grippe. (Role for antibody to neuraminidase in protecting against influenza)." La Semaine des hôpitaux de Paris75(23-24) : 933-941.
 +
 +
16. Babai I, Barenholz Y, Zakay-Rones Z, Greenbaum E, Samira S, Hayon I, Rochman M and Kedar E (2001). "A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective antineuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains." Vaccine20(3-4) : 505-15.
 +
 +
17. Baigent SJ and McCauley JW (2001). "Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture." Virus Res79(1-2) : 177-85.
 +
 +
18. Baigent SJ and McCauley JW (2003). "Influenza type A in humans, mammals and birds : determinants of virus virulence, host-range and interspecies transmission." Bioessays25(7) : 657-71.
 +
 +
19. Banks J, Speidel E and Alexander DJ (1998). "Characterisation of an avian influenza A virus isolated from a human  : is an intermediate host necessary for the emergence of pandemic influenza viruses?" Archives of virology143(4) : 781-787.
 +
 +
20. Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, Capua I, Cordioli P, Fioretti A and Alexander DJ (2001). "Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy." Archives of virology146(5) : 963-973.
 +
 +
21. Bantia S, Arnold CS, Parker CD, Upshaw R and Chand P (2005). "Anti-influenza virus activity of peramivir in mice with single intramuscular injection." Antiviral Res.
 +
 +
22. Beby-Defaux A, Giraudeau G, Bouguermouh S and Agius G (2003). "La grippe humaine : aspects virologiques, épidémiologie et diagnostic virologique. (Influenza : virological aspects, epidemiology and virological diagnosis)." Médecine et maladies infectieuses33(3) : 134-142.
 +
 +
23. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S and Yuen KY (2005). "Avian influenza A (H5N1) infection in humans." N Engl J Med 353(13) : 1374-85.
 +
 +
24. Bennink JR and Palmore TN (2004). "The promise of siRNAs for the treatment of influenza." Trends Mol Med10(12) : 571-4.
 +
 +
25. Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Galprin I, Gluck R, Zurbriggen R and Kedar E (2003). "Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents." Vaccine 21(23) : 3169-78.
 +
 +
26. Ben-Yehuda A, Joseph A, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Barenholz Y and Kedar E (2003). "Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults." J Med Virol69(4) : 560-7.

Version du 10 avril 2020 à 13:22

Liens utiles

17.Conseils aux voyageurs http://www.diplomatie.fr/voyageurs/etrangers/avis/conseils/default2.asp

18.FAO des Nations Unies http://www.fao.org/ag/againfo/subjects/en/health/diseases-cards/avian_update.html

19.Eurosurveillance http://www.eurosurveillance.org/index-01.asp

20.Maladies émergentes http://www.promedmail.org/pls/askus/f?p=2400:1000

Références bibliographiques

1. FAO, OIE and OMS (2005). "Lignes directrices sur la prévention et le contrôle de l'influenza aviaire." Organisation des Nations Unies pour l'alimentation et l'agriculture-Organisation Internationale des épizooties- Organisation Mondiale de la Santé.

2. OMS (2003). "Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses. Interim biosafety risk assessment." Organisation Mondiale de la Santé.

3. OMS (2004). "Exposures that may have put a person at risk of becoming infected with influenza A(H5N1)." Organisation Mondiale de la Santé.

4. OMS (2005). "WHO guidance on development of influenza vaccine reference viruses by reverse genetics." Organisation Mondiale de la Santé.

5. OMS (2005). "Recommended laboratory tests to identify avian influenza A virus in specimens from humans." Organisation Mondiale de la Santé.

6. OMS (2006). "Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO." Organisation Mondiale de la Santé.

7. OMS (2006). "Avian influenza, including influenza A (H5N1), in humans : WHO interim infection control guideline for health care facilities." Organisation Mondiale de la Santé.

8. UPMC (2005). "Peramivir : Single Dose Prophylaxis for Flu?" Center for Biosecurity of UPMC, for a briefing on Capitol Hill.

9. Abed Y, Hardy I, Li Y and Boivin G (2002). "Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada." Journal of medical virology67(4) : 589-595.

10. Al Faress S, Cartet G, Ferraris O, Norder H, Valette M and Lina B (2005). "Divergent genetic evolution of hemagglutinin in influenza A H1N1 and A H1N2 subtypes isolated in the south-France since the winter of 2001-2002." J Clin Virol33(3) : 230-6.

11. Alexander DJ, Van RK and Pensaert M (2000). "A review of avian influenza in different bird species." Veterinary microbiology  : (Amsterdam)74(1-2) : 3-13.

12. Amonsin A, Payungporn S, Theamboonlers A, Thanawongnuwech R, Suradhat S, Pariyothorn N, Tantilertcharoen R, Damrongwantanapokin S, Buranathai C, Chaisingh A, Songserm T and Poovorawan Y (2005). "Genetic characterization of H5N1 influenza A viruses isolated from zoo tigers in Thailand." Virology 344(2) : 480-491.

13. Apisarnthanarak A, Erb S, Stephenson I, Katz JM, Chittaganpitch M, Sangkitporn S, Kitphati R, Thawatsupha P, Waicharoen S, Pinitchai U, Apisarnthanarak P, Fraser VJ and Mundy LM (2005). "Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to Avian influenza (H5N1) in a tertiary care center." Clin Infect Dis 40(2) : e16-8.

14. Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, Auwanit W, Thawatsupha P, Chittaganpitch M, Saeng-Aroon S, Waicharoen S, Apisarnthanarak P, Storch GA, Mundy LM and Fraser VJ (2004). "Atypical avian influenza (H5N1)." Emerg Infect Dis 10(7) : 1321-4.

15. Aymard M, Gerentes L and Kessler N (1999). "Place des anticorps antineuraminidase dans la protection contre la grippe. (Role for antibody to neuraminidase in protecting against influenza)." La Semaine des hôpitaux de Paris75(23-24) : 933-941.

16. Babai I, Barenholz Y, Zakay-Rones Z, Greenbaum E, Samira S, Hayon I, Rochman M and Kedar E (2001). "A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective antineuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains." Vaccine20(3-4) : 505-15.

17. Baigent SJ and McCauley JW (2001). "Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture." Virus Res79(1-2) : 177-85.

18. Baigent SJ and McCauley JW (2003). "Influenza type A in humans, mammals and birds : determinants of virus virulence, host-range and interspecies transmission." Bioessays25(7) : 657-71.

19. Banks J, Speidel E and Alexander DJ (1998). "Characterisation of an avian influenza A virus isolated from a human  : is an intermediate host necessary for the emergence of pandemic influenza viruses?" Archives of virology143(4) : 781-787.

20. Banks J, Speidel ES, Moore E, Plowright L, Piccirillo A, Capua I, Cordioli P, Fioretti A and Alexander DJ (2001). "Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy." Archives of virology146(5) : 963-973.

21. Bantia S, Arnold CS, Parker CD, Upshaw R and Chand P (2005). "Anti-influenza virus activity of peramivir in mice with single intramuscular injection." Antiviral Res.

22. Beby-Defaux A, Giraudeau G, Bouguermouh S and Agius G (2003). "La grippe humaine : aspects virologiques, épidémiologie et diagnostic virologique. (Influenza : virological aspects, epidemiology and virological diagnosis)." Médecine et maladies infectieuses33(3) : 134-142.

23. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S and Yuen KY (2005). "Avian influenza A (H5N1) infection in humans." N Engl J Med 353(13) : 1374-85.

24. Bennink JR and Palmore TN (2004). "The promise of siRNAs for the treatment of influenza." Trends Mol Med10(12) : 571-4.

25. Ben-Yehuda A, Joseph A, Barenholz Y, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Galprin I, Gluck R, Zurbriggen R and Kedar E (2003). "Immunogenicity and safety of a novel IL-2-supplemented liposomal influenza vaccine (INFLUSOME-VAC) in nursing-home residents." Vaccine 21(23) : 3169-78.

26. Ben-Yehuda A, Joseph A, Zeira E, Even-Chen S, Louria-Hayon I, Babai I, Zakay-Rones Z, Greenbaum E, Barenholz Y and Kedar E (2003). "Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults." J Med Virol69(4) : 560-7.

Récupérée de « https://wicri-demo.istex.fr/Wicri/Sante/fr/index.php?title=Grippe_aviaire_et_transmission_chez_l%27homme_(2006)_Delvallée/Documentation&oldid=7355 »